A Clinical Trial to Evaluate the Clinical Efficacy of Cyclosporine 0.1% (Ikervis®) for Moderate to Severe Dry Eye Patients. (IKE-03-SWITCHING)

NCT04775303 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Moderate to Severe Dry Eye

Interventions

DRUG: Cyclosporine 0.1% (Ikervis®) eye drop

Sponsor

Yonsei University